# Aurinia Pharmaceuticals Inc.: Form 8-K, filed Nov 2, 2023

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: 8-K
- Filed: 2023-11-02
- Accepted by EDGAR: Nov 2, 2023, 06:01 ET
- Period: 2023-11-02
- Accession: 0001600620-23-000043
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000160062023000043/auph-20231102.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000160062023000043/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000160062023000043/auph-20231102.htm

Filed Nov 2, 2023.
Source: SEC EDGAR, the filing index for accession 0001600620-23-000043. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.